
Sichuan Kelun-Biotech Biopharmaceutical Investor Relations Material
Latest events

H1 2025
Sichuan Kelun-Biotech Biopharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Access all reports
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based company engaged in the research, development, and manufacturing of biopharmaceutical products. The company focuses on innovative therapeutics across various medical fields, including oncology, infectious diseases, and autoimmune disorders. It develops biologic drugs and biosimilars, utilizing advanced biotechnological platforms to address unmet medical needs. Sichuan Kelun-Biotech serves both domestic and international pharmaceutical markets. The company is headquartered in Chengdu, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd


H1 2025
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd


H1 2025
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
6990
Country
🇭🇰 Hong Kong